These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2560848)

  • 1. [The significance of humoral immunity in post-vaccination resistance of mice to tick-borne encephalitis].
    Nikonova AN; Rozhkova LV; Sokolova ED
    Tr Inst Im Pastera; 1989; 65():84-90. PubMed ID: 2560848
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined effects of immunomodulators and specific inactivated vaccines against alpha- and flavivirus infections].
    Barinskiĭ IF; Lazarenko AA; Alimbarova LM; Davydova AA
    Med Parazitol (Mosk); 2011; (1):17-20. PubMed ID: 21480553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The mechanism of forming immunity in tick-borne encephalitis].
    Vasil'ev NV; Fedorov IuV; Vasil'eva OA
    Tr Inst Im Pastera; 1989; 65():77-84. PubMed ID: 2629190
    [No Abstract]   [Full Text] [Related]  

  • 5. [Laboratory methods of controlling immunogenicity of vaccines against tick-borne encephalitis].
    Sokolova ED
    Tr Inst Im Pastera; 1989; 65():90-8. PubMed ID: 2560849
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA
    Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
    Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against tick-borne encephalitis--distant evaluation.
    Bobrowska E; Grzeszczuk A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus.
    Aberle JH; Aberle SW; Kofler RM; Mandl CW
    J Virol; 2005 Dec; 79(24):15107-13. PubMed ID: 16306582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of antibody formation after vaccination against tick-borne encephalitis].
    Pazdiora P; Januska J
    Epidemiol Mikrobiol Imunol; 2004 Feb; 53(1):17-21. PubMed ID: 15052830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid vaccination protocols for commercial vaccines against tick-borne encephalitis.
    Stephenson JR; Lee JM; Easterbrook LM; Timofeev AV; Elbert LB
    Vaccine; 1995; 13(8):743-6. PubMed ID: 7483789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field effectiveness of vaccination against tick-borne encephalitis.
    Heinz FX; Holzmann H; Essl A; Kundi M
    Vaccine; 2007 Oct; 25(43):7559-67. PubMed ID: 17869389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the immunizing potency of tick-borne encephalitis vaccines.
    Gall W
    Acta Microbiol Pol A; 1973; 5(3):279-85. PubMed ID: 4769562
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vaccination against tick-borne encephalitis using an inactivated vaccine].
    Duniewicz M; Markvart K; Vlasimská H; Heinz F; Kulková H
    Cas Lek Cesk; 1983 Aug; 122(32-33):1000-2. PubMed ID: 6627307
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two severe cases of tick-borne encephalitis despite complete active vaccination--the significance of neutralizing antibodies.
    Bender A; Jäger G; Scheuerer W; Feddersen B; Kaiser R; Pfister HW
    J Neurol; 2004 Mar; 251(3):353-4. PubMed ID: 15015020
    [No Abstract]   [Full Text] [Related]  

  • 17. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Active immunization against tick-borne encephalitis in the elderly].
    Biró J; Regius O
    Z Gerontol; 1985; 18(6):337-9. PubMed ID: 3879415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunogenicity and protective properties for mice of the formalin-inactivated tick-borne encephalitis virus].
    Gut W; Jarzabek Z; Sadowski W; Kańtoch M
    Med Dosw Mikrobiol; 1986; 38(4):234-40. PubMed ID: 3561097
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of a natural interferon inducer (RFf2) on the formation of vaccinal immunity to tick-borne encephalitis].
    Fomina AN; Nosik NN; Bukata LA; Davydova AA; Barinskiĭ NF
    Antibiotiki; 1979 Jan; 24(1):67-71. PubMed ID: 426497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.